http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111072737-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 |
filingDate | 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111072737-B |
titleOfInvention | A kind of lignan compound and its application |
abstract | The invention relates to a lignan compound isolated and purified from Polytubella and its application, realizing its application in the preparation of antioxidants and anti-helicobacter pylori drugs. The name of the compound is: (2S,3R,4S,5S,6R)-2-(4'-((3a"R,6a"R)-4"-(3"'-bromine-4"', 5"'-dihydroxyphenyl)-hexahydrofuran[3",4"-c]furan-1"-yl)-2',6'-dimethoxyphenoxy)-6-(hydroxymethyl ) Tetrahydro-2H-pyran-3,4,5-triol.Compound of the present invention is a kind of novel compound, proves that compound of the present invention has antioxidant activity and has inhibition and killing pylorus through pharmacodynamic experiment The action of Helicobacter provides technical support for the application of the compound in the preparation of antioxidants and anti-Helicobacter pylori drugs. |
priorityDate | 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.